FrancophonIA/ELRC3.0 huggingface dataset:
English: Packs of 1 bottle of 30 tablets or bottles of 180 tablets without outer carton.
Slovenian: Pakiranja z 1 vsebnikom, ki vsebuje 30 tablet ali z vsebnikom, ki vsebuje 180 tablet brez zunanje škatle.
English: EU/1/14/952/005 90 sachets EU/1/14/952/006 90 sachets (with a dosing spoon)
Slovenian: EU/1/14/952/006 90 vrečic (z odmerno žličko)
English: He will base the dose on your serum phosphorus level.
Slovenian: Zdravnik bo odmerek določil glede na koncentracijo fosfata v serumu.
English: The second study demonstrated that sevelamer carbonate powder dosed three times per day was equivalent to sevelamer hydrochloride tablets dosed three times per day in 31 hyperphosphataemic (defined as serum phosphorus levels ≥ 1.78 mmol/L) haemodialysis patients over two randomised 4 week treatment periods (mean serum phosphorus time-weighted averages were 1.6 ± 0.5 mmol/L for sevelamer carbonate powder and 1.7 ± 0.4 mmol/L for sevelamer hydrochloride tablets).
Slovenian: Druga študija je pokazala, da so bili trije dnevni odmerki praška sevelamerijevega karbonata enakovredni trem dnevnim odmerkom tablet sevelamerijevega klorida pri 31 bolnikih s hiperfosfatemijo na hemodializi (opredeljeno kot ravni fosforja v serumu ≥ 1,78 mmol/l), zdravljenih v dveh naključnih 4-tedenskih obdobjih (srednje časovno uteženo povprečje fosforja v serumu je bilo 1,6 ± 0,5 mmol/l za prašek sevelamerijevega karbonata in 1,7 ± 0,4 mmol/l za tablete sevelamerijevega klorida).
English: Powder for oral suspension 2.4 g powder
Slovenian: FARMACEVTSKA OBLIKA IN VSEBINA prašek za peroralno suspenzijo 2,4 g praška
English: This medicine should be used with other treatments such as calcium supplements and vitamin D to prevent the development of bone disease.
Slovenian: To zdravilo se sme uporabljati sočasno s terapijo preventive razvoja bolezni kosti pri kateri se dodaja kalcij in vitamin D.
English: Difficulties swallowing the Sevelamer carbonate Winthrop tablet have been reported.
Slovenian: Poročali so o težavah s požiranjem tablet Sevelamerijev karbonat Winthrop.
English: The safety and efficacy of Sevelamer carbonate Winthrop in children below the age of 6 years or in children with a BSA (Body Surface Area) below 0.75 m2 have not been established.
Slovenian: Varnost in učinkovitost zdravila Sevelamerijev karbonat Winthrop pri otrocih, mlajših od 6 let, niti pri otrocih s telesno površino manj kot 0,75 m2 nista ugotovljeni.
English: EU/1/14/952/002 60 sachets EU/1/14/952/003 90 sachets
Slovenian: EU/1/14/952/003 90 vrečic
English: How to store Sevelamer carbonate Winthrop 6.
Slovenian: Shranjevanje zdravila Sevelamer carbonate Winthrop 6.
English: Sevelamer carbonate Winthrop 800 mg film-coated tablets sevelamer carbonate
Slovenian: Sevelamerijev karbonat Winthrop 800 mg filmsko obložene tablete sevelamerijev karbonat
English: Sevelamer carbonate Winthrop contains sevelamer, a non-absorbed phosphate binding crosslinked polymer.
Slovenian: Zdravilo Sevelamerijev karbonat Winthrop vsebuje sevelamer, neabsorptiven premrežen polimer, ki veže fosfate.
English: Sevelamer carbonate Winthrop 800 mg film-coated tablets
Slovenian: IME ZDRAVILA Sevelamerijev karbonat Winthrop 800 mg filmsko obložene tablete
English: Sevelamer carbonate Winthrop contains the active substance sevelamer carbonate.
Slovenian: Zdravilo Sevelamerijev karbonat Winthrop vsebuje učinkovino sevelamerijev karbonat .
English: C. OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION • Periodic safety update reports (PSURs)
Slovenian: • Redno posodobljena poročila o varnosti zdravila (PSUR)
English: The first study demonstrated that sevelamer carbonate tablets dosed three times per day was equivalent to sevelamer hydrochloride tablets dosed three times per day in 79 haemodialysis patients treated over two randomised 8 week treatment periods (mean serum phosphorus time-weighted averages were 1.5 ± 0.3 mmol/L for both sevelamer carbonate and sevelamer hydrochloride).
Slovenian: Prva študija je pokazala, da so bili trije dnevni odmerki tablet sevelamerijevega karbonata enakovredni trem dnevnim odmerkom tablet sevelamerijevega klorida pri 79 bolnikih na hemodializi, zdravljenih v dveh naključnih 8-tedenskih obdobjih (srednje časovno uteženo povprečje fosforja v serumu je bilo 1,5 ± 0,3 mmol/l za sevelamerijev karbonat kot tudi za sevelamerijev klorid).
English: The safety and efficacy of Sevelamer carbonate Winthrop in children below the age of 6 years or in children with a BSA below 0.75 m2 have not been established.
Slovenian: Varnost in učinkovitost zdravila Sevelamerijev karbonat Winthrop nista ugotovljeni pri otrocih, mlajših od 6 let, niti pri otrocih s telesno površino manj kot 0,75 m2.
English: If you have missed one dose, this dose should be omitted and the next dose should be taken at the usual time with a meal.
Slovenian: Če ste pozabili vzeti zdravilo Sevelamerijev karbonat Winthrop Če pozabite vzeti odmerek, ga izpustite in naslednji odmerek vzemite kot običajno s hrano.
English: Total daily dose of sevelamer carbonate to be taken over 3 meals/snacks per day
Slovenian: Skupni dnevni odmerek sevelamerijevega karbonata vzet pri 3 obroki/prigrizki na dan
English: EU/1/14/952/001 180 film-coated tablets
Slovenian: ŠTEVILKA(E) DOVOLJENJA (DOVOLJENJ) ZA PROMET EU/1/14/952/001 180 filmsko obloženih tablet
English: The safety and efficacy of Sevelamer carbonate Winthrop in children over 6 year of age and a BSA >0.75 m2 have been established.
Slovenian: Varnost in učinkovitost zdravila Sevelamerijev karbonat Winthrop sta ugotovljeni pri otrocih, starejših od 6 let in s telesno površino > 0,75 m2.
English: You must take Sevelamer carbonate Winthrop as prescribed by your doctor.
Slovenian: Pri jemanju zdravila Sevelamerijev karbonat Winthrop natančno upoštevajte navodila svojega zdravnika.
English: The 0.4 g dose of Sevelamer carbonate Winthrop powder must be measured using the dosing spoon provided in the carton.
Slovenian: 0,4 g odmerek praška zdravila Sevelamerijev karbonat Winthrop je treba odmeriti z odmerno žličko.
English: o Hold the dosing spoon horizontally and pour the powder out of the sachet into the dosing spoon.
Slovenian: o Odmerno žličko držite vodoravno in vsipajte prašek iz vrečice na odmerno žličko.
English: The use of sevelamer carbonate powder in patients with a history of difficulty swallowing should be considered.
Slovenian: Pri bolnikih z anamnezo težav s požiranjem je potrebno razmisliti o uporabi praška sevelamerijevega karbonata.
English: Intestinal obstruction, Ileus/subileus, Intestinal perforation1, Gastrointestinal hemorrhage1, Intestinal ulceration1, Gastrointestinal necrosis1, Colitis1, Intestinal mass1
Slovenian: Bolezni prebavil navzea, bruhanje, bolečine v zgornjem delu trebuha, zaprtost diareja, dispepsija, flatulenca, bolečine v trebuhu obstrukcija črevesa, ileus/subileus in perforacija črevesa1, gastrointestinalna krvavitev*1, črevesna razjeda1, gastrointestinalna nekroza1, kolitis1, masa v črevesu1
English: Sevelamer carbonate Winthrop is also indicated for the control of hyperphosphataemia in adult patients with chronic kidney disease (CKD) not on dialysis with serum phosphorus ≥ 1.78 mmol/L.
Slovenian: Zdravilo Sevelamerijev karbonat Winthrop je indicirano tudi za nadzor hiperfosfatemije pri odraslih bolnikih s kronično boleznijo ledvic (KBL Disease), ki niso na dializi, in imajo raven fosforja v serumu ≥ 1,78 mmol/l.
English: Propylene glycol alginate (E405) Citrus Cream flavour Sodium chloride Sucralose
Slovenian: 6.1 Seznam pomožnih snovi propilenglikol alginat (E405) aroma citrusove kreme natrijev klorid sukraloza železov oksid rumeni (E172)
English: (Instructions for presentation WITH dosing spoon) To achieve the correct dose, the dosing spoon provided in the carton must be used to measure 0.4 g of Sevelamer carbonate Winthrop.
Slovenian: Za dosego ustreznega odmerka je treba uporabiti odmerno žličko, ki se nahaja v škatli in s katero odmerimo 0,4 g praška zdravila Sevelamerijev karbonat Winthrop.
English: PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING LABEL - SACHETS
Slovenian: PODATKI NA STIČNI OZ. PRIMARNI OVOJNINI OZNAKA - VREČICE
English: • if you have bowel obstruction.
Slovenian: • če imate zaporo črevesa.
English: Sevelamer carbonate Winthrop should be used within the context of a multiple therapeutic approach, which could include calcium supplement, 1,25-dihydroxy Vitamin D3 or one of its analogues to control the development of renal bone disease.
Slovenian: Zdravilo Sevelamerijev karbonat Winthrop je treba uporabljati v smislu večstranskega pristopa zdravljenja, ki lahko vključuje kalcijev dodatek, 1,25-dihidroksi vitamin D3 ali kakšen njegov analog, za nadziranje razvoja renalne osteodistrofije.
English: Tell your doctor if you are taking, have recently taken or might take any other medicines.
Slovenian: Druga zdravila in zdravilo Sevelamerijev karbonat Winthrop Obvestite svojega zdravnika, če jemljete, ste pred kratkim jemali ali pa boste morda začeli jemati katero koli drugo zdravilo.
English: Sevelamer carbonate Winthrop 2.4 g powder for oral suspension sevelamer carbonate
Slovenian: Sevelamerijev karbonat Winthrop 2,4 g prašek za peroralno suspenzijo sevelamerijev karbonat
English: Caution should be exercised when prescribing PPI to patients concomitantly treated with Sevelamer carbonate Winthrop.
Slovenian: Bolnikom, ki sočasno prejemajo zdravilo Sevelamerijev karbonat Winthrop, je treba zaviralce protonske črpalke predpisovati previdno.
English: Interaction studies have not been conducted in patients on dialysis.
Slovenian: Pri bolnikih, ki se zdravijo s hemodializo, niso preučevali medsebojnega delovanja.
English: Sevelamer carbonate Winthrop 0.8 g powder for oral suspension sevelamer carbonate
Slovenian: Sevelamerijev karbonat Winthrop 0,8 g prašek za peroralno suspenzijo sevelamerijev karbonat
English: Sevelamer carbonate Winthrop 2.4 g
Slovenian: PODATKI V BRAILLOVI PISAVI Sevelamerijev karbonat Winthrop 2,4 g
English: EU/1/14/952/004 30 film-coated tablets
Slovenian: ŠTEVILKA(E) DOVOLJENJA (DOVOLJENJ) ZA PROMET EU/1/14/952/004 30 filmsko obloženih tablet
English: In patients with secondary hyperparathyroidism sevelamer carbonate should be used within the context of a multiple therapeutic approach, which could include calcium as supplements, 1,25-dihydroxy Vitamin D3 or one of its analogues to lower the iPTH levels.
Slovenian: Pri bolnikih s sekundarnim hiperparatiroidizmom je treba sevelamerijev karbonat uporabljati v smislu večstranskega pristopa zdravljenja, ki lahko vključuje kalcij kot dodatke, 1,25-dihidroksi vitamin D3 ali kakšen njegov analog za nižanje ravni iPTH.
English: Sevelamer carbonate Winthrop 2.4 g powder for oral suspension
Slovenian: IME ZDRAVILA Sevelamerijev karbonat Winthrop 2,4 g prašek za peroralno suspenzijo
English: Iron oxide black (E172) Propylene glycol Isopropyl alcohol Hypromellose (E464)
Slovenian: Filmska obloga: hipromeloza (E464) diacetilirani monogliceridi Črnilo: črn železov oksid (E172) propilenglikol izopropil alkohol hipromeloza (E464) 6.2 Inkompatibilnosti Navedba smiselno ni potrebna.
English: Sevelamer carbonate Winthrop 0.8 g powder for oral suspension
Slovenian: IME ZDRAVILA Sevelamerijev karbonat Winthrop 0,8 g prašek za peroralno suspenzijo
English: For adult patients, serum phosphorus levels must be monitored and the dose of sevelamer carbonate titrated by 0.8 g three times per day (2.4 g/day) increments every 2-4 weeks until an acceptable serum phosphorus level is reached, with regular monitoring thereafter.
Slovenian: Ravni fosforja v serumu je treba pri odraslih nadzirati in odmerek sevelamerijevega karbonata titrirati z 0,8 g odmerkom trikrat na dan (2,4 g/ dan) vsake 2-4 tedne, dokler ni dosežena sprejemljiva raven fosforja v serumu.
English: Each sachet contains 2.4g of sevelamer carbonate.
Slovenian: Ena vrečica vsebuje 2,4g sevelamerijevega karbonata.
English: This medicine contains less than 1 mmol sodium (23 mg) per tablet that is to say essentially ‘sodium-free'.
Slovenian: To zdravilo vsebuje manj kot 1 mmol natrija (23 mg) na tableto, kar v bistvu pomeni "brez natrija".
English: Other side effects have been reported in patients taking Sevelamer carbonate Winthrop:
Slovenian: Pri bolnikih, ki jemljejo zdravilo Sevelamerijev karbonat Winthrop , so poročali o drugih neželenih učinkih:
English: Each sachet contains 0.8 g of sevelamer carbonate.
Slovenian: Vsaka vrečica vsebuje 0,8 g sevelamerijevega karbonata, kot je navedeno na vrečici.
English: This medicinal product contains less than 1 mmol sodium (23 mg) per tablet that is to say essentially ‘sodium-free'.
Slovenian: Pomožne snovi To zdravilo vsebuje manj kot 1 mmol natrija (23 mg) na tableto, kar v bistvu pomeni "brez natrija".
English: Powder for oral suspension.
Slovenian: FARMACEVTSKA OBLIKA prašek za peroralno suspenzijo Svetlorumeni prašek.
English: This medicine contains less than 1 mmol sodium (23 mg) per sachet that is to say essentially ‘sodium-free'.
Slovenian: To zdravilo vsebuje manj kot 1 mmol natrija (23 mg) na vrečico, kar v bistvu pomeni "brez natrija".
English: (Instructions for presentation WITHOUT dosing spoon) If a dose of 0.4 g is to be administered, please use the dedicated 0.8 g powder presentation with dosing spoon.
Slovenian: Če je potrebno zaužiti 0,4 g odmerek, prosimo uporabite temu namenjeno 0,8 g obliko praška z odmerno žličko.
English: A 0,4 g dosing spoon is provided in the carton.
Slovenian: (Navodila za obliko z odmerno žličko) 0,4 g odmerna žlička se nahaja v škatli.
English: This medicinal product contains less than 1 mmol sodium (23 mg) per sachet that is to say essentially ‘sodium-free'.
Slovenian: Vsebnost natrija To zdravilo vsebuje manj kot 1 mmol natrija (23 mg) na vrečico, kar v bistvu pomeni "brez natrija".
English: Powder for oral suspension 0.8 g powder
Slovenian: FARMACEVTSKA OBLIKA IN VSEBINA prašek za peroralno suspenzijo 0,8 g sevelamerijevega karbonata
English: The studies included 1,159 patients and lasted 26 and 18 weeks, respectively.
Slovenian: V študijah je sodelovalo 1 159 bolnikov, trajali pa sta 26 oziroma 18 tednov.
English: This medicine is the same as Azilect, which is already authorised in the European Union (EU).
Slovenian: To zdravilo je enako zdravilu Azilect, ki je že odobreno v Evropski uniji (EU).
English: The standard dose is one tablet once a day.
Slovenian: Običajni odmerek zdravila je ena tableta na dan.
English: The patients then lose their ability to control their movements reliably.
Slovenian: Bolniki posledično izgubijo zmožnost zanesljivega nadzora nad svojimi gibi.
English: The full EPAR and risk management plan summary for Rasagiline ratiopharm can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Slovenian: Celotno evropsko javno poročilo o oceni zdravila (EPAR) in povzetek načrta obvladovanja tveganj za zdravilo Razagilin ratiopharm sta na voljo na spletni strani agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: A fall in the UPDRS score indicates an improvement in symptoms, while a rise indicates a worsening of symptoms.
Slovenian: Zmanjšanje na lestvici UPDRS označuje izboljšanje simptomov, povečanje pa poslabšanje simptomov.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Rasagiline ratiopharm on 12 January 2015.
Slovenian: Evropska komisija je dovoljenje za promet z zdravilom Razagilin ratiopharm, veljavno po vsej Evropski uniji, izdala 12. januarja 2015.
English: This is a summary of the European public assessment report (EPAR) for Rasagiline ratiopharm.
Slovenian: To je povzetek evropskega javnega poročila o oceni zdravila (EPAR) za zdravilo Razagilin ratiopharm.
English: Fluctuations happen when the effects of the medication wear off and symptoms reemerge.
Slovenian: Do nihanj pride, ko začnejo učinki zdravila popuščati in se simptomi ponovno pojavijo.
English: Similar reductions in time spent in the ‘off' state were seen in patients taking entacapone.
Slovenian: Podobno zmanjšanje časa v stanju „izklopa“ je bilo opaženo pri bolnikih, ki so prejemali entakapon.
English: Rasagiline ratiopharm is available as tablets (1 mg).
Slovenian: Zdravilo Razagilin ratiopharm je na voljo v obliki tablet (1 mg).
English: They are linked to a reduction in the effect of levodopa, when the patient experiences sudden switches between being ‘on' and able to move, and being ‘off' and having difficulty moving about.
Slovenian: Nihanja so povezana so z zmanjšanjem učinka levodope, ko bolnik doživlja nenadne preskoke med stanjem „vklopa“, ko se lahko giblje, in stanjem „izklopa“, ko ima z gibanjem težave.
English: It must also not be used with pethidine (a painkiller).
Slovenian: Prav tako se ne sme uporabljati skupaj s petidinom (sredstvom proti bolečinam).
English: In one of the studies, a 26-week treatment with Rasagiline ratiopharm resulted in an average fall of 0.13 points in UPDRS (a standard scale for assessing symptoms of Parkinson's disease) from a starting value of 24.69 compared with a rise of 4.07 points in the patients taking placebo from a starting value of 24.54.
Slovenian: V eni od študij je 26-tedensko zdravljenje z zdravilom Razagilin ratiopharm število točk po lestvici UPDRS (standardni lestvici za ocenjevanje simptomov Parkinsonove bolezni) zmanjšalo z začetne vrednosti 24,69 za povprečno 0,13, pri bolnikih, ki so prejemali placebo, pa se je število točk z začetne vrednosti 24,54 zvišalo za povprečno 4,07.
English: Patients with mild liver problems should use Rasagiline ratiopharm with caution and should stop treatment if their liver problems get worse.
Slovenian: Bolniki z blagimi težavami z jetri morajo zdravilo Razagilin ratiopharm uporabljati previdno in morajo prenehati z zdravljenjem, če se njihove težave z jetri poslabšajo.
English: In both studies, patients taking Rasagiline ratiopharm spent an average of around one hour less in the ‘off' state than those taking placebo.
Slovenian: V obeh študijah so bolniki, ki so prejemali zdravilo Razagilin ratiopharm, preživeli v povprečju približno eno uro manj v stanju „izklopa“ kot bolniki, ki so prejemali placebo.
English: The Committee for Medicinal Products for Human Use (CHMP) decided that Rasagiline ratiopharm's benefits are greater than its risks and recommended that it be given marketing authorisation.
Slovenian: Odbor za zdravila za uporabo v humani medicini (CHMP) pri agenciji je zaključil, da so koristi zdravila Razagilin ratiopharm večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
English: What measures are being taken to ensure the safe and effective use of Rasagiline ratiopharm?
Slovenian: Kateri ukrepi se izvajajo za zagotovitev varne in učinkovite uporabe zdravila Razagilin ratiopharm?
English: The company that makes Azilect has agreed that its scientific data can be used for Rasagiline ratiopharm (‘informed consent').
Slovenian: Družba, ki proizvaja zdravilo Azilect, se strinja, da se lahko znanstveni podatki o tem zdravilu uporabijo tudi za zdravilo Razagilin ratiopharm („uporaba dokumentacije s soglasjem“).
English: By increasing levels of dopamine in the parts of the brain that control movement and coordination, Rasagiline ratiopharm improves the signs and symptoms of Parkinson's disease, such as stiffness and slowness of movement.
Slovenian: S povečevanjem ravni dopamina v delih možganov, ki nadzorujejo gibe in koordinacijo, zdravilo Razagilin ratiopharm lajša znake in simptome Parkinsonove bolezni, kot sta okornost in počasnost gibov.
English: The most common side effect with Rasagiline ratiopharm (seen in more than 1 patient in 10) is headache.
Slovenian: Najpogostejši neželeni učinek zdravila Razagilin ratiopharm (ki lahko prizadene več kot 1 osebo od 10) je glavobol.
English: Rasagiline ratiopharm has been shown in three studies, involving 1,563 patients, to be effective in both relieving the symptoms of Parkinson's disease and in reducing the time patients spend in their ‘off' periods.
Slovenian: Zdravilo Razagilin ratiopharm je v treh študijah, v katere je bilo vključenih 1 563 bolnikov, učinkovito olajšalo simptome Parkinsonove bolezni in skrajšalo čas, ki so ga bolniki preživeli v stanju „izklopa“.
English: Rasagiline ratiopharm is a medicine used to treat adults with Parkinson's disease (a progressive brain disorder that causes shaking, slow movement and muscle stiffness).
Slovenian: Zdravilo Razagilin ratiopharm se uporablja za zdravljenje odraslih s Parkinsonovo boleznijo (napredujočo boleznijo možganov, ki povzroča tresenje, počasno gibanje in okorelost mišic).
English: It blocks the enzyme monoamine oxidase type B, which breaks down the neurotransmitter dopamine in the brain.
Slovenian: Razagilin blokira encim monoaminooksidaza tipa B, ki razgrajuje živčni prenašalec dopamin v možganih.
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Rasagiline ratiopharm, including the appropriate precautions to be followed by healthcare professionals and patients.
Slovenian: V skladu s tem načrtom so bile v povzetek glavnih značilnosti zdravila Razagilin ratiopharm in navodilo za njegovo uporabo vključene informacije o varnosti, vključno s previdnostnimi ukrepi, ki jih morajo upoštevati zdravstveni delavci in bolniki.
English: A risk management plan has been developed to ensure that Rasagiline ratiopharm is used as safely as possible.
Slovenian: Za zagotovitev čim varnejše uporabe zdravila Razagilin ratiopharm je bil pripravljen načrt obvladovanja tveganj.
English: It is not intended to provide practical advice on how to use Rasagiline ratiopharm.
Slovenian: Povzetek ni namenjen zagotavljanju praktičnih nasvetov o njegovi uporabi.
English: For more information about treatment with Rasagiline ratiopharm, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Slovenian: Za več informacij o zdravljenju z zdravilom Razagilin ratiopharm preberite navodilo za uporabo (ki je prav tako del EPAR) ali se posvetujte z zdravnikom ali farmacevtom.
English: There should be at least 14 days between stopping treatment with Rasagiline ratiopharm and starting treatment with another monoamine-oxidase inhibitor or with pethidine.
Slovenian: Med prenehanjem zdravljenja z zdravilom Razagilin ratiopharm in začetkom zdravljenja z drugim zaviralcem monoaminooksidaz ali petidinom mora preteči najmanj 14 dni.
English: In the two other studies, Rasagiline ratiopharm was given as ‘add-on' to patients with later stage disease who were already being treated with levodopa, and compared with placebo and another medicine entacapone (also used as add-ons).
Slovenian: V dveh drugih študijah so zdravilo Razagilin ratiopharm dajali kot dopolnilno zdravljenje bolnikom z napredovalo boleznijo, ki so se že zdravili z levodopo, ter ga primerjali s placebom in drugim zdravilom entakaponom (ki se prav tako uporablja kot dopolnilno zdravljenje).
English: Rasagiline ratiopharm can be used either alone, or as an add-on to levodopa (another medicine used in Parkinson's disease) in patients who are having ‘fluctuations' towards the end of the period between levodopa doses.
Slovenian: Zdravilo Razagilin ratiopharm se lahko uporablja samostojno ali kot dodatek levodopi (drugemu zdravilu, ki se uporablja pri Parkinsonovi bolezni) pri bolnikih z „nihanji“ proti koncu obdobja med dvema odmerkoma levodope.
English: The active substance in Rasagiline ratiopharm, rasagiline, is a ‘monoamine oxidase B inhibitor'.
Slovenian: Zdravilna učinkovina zdravila Razagilin ratiopharm, razagilin, je „zaviralec monoaminooksidaz tipa B“.
English: For practical information about using Rasagiline ratiopharm, patients should read the package leaflet or contact their doctor or pharmacist.
Slovenian: Za praktične informacije o uporabi zdravila Razagilin ratiopharm naj bolniki preberejo navodilo za uporabo ali se posvetujejo z zdravnikom ali farmacevtom.